Bacterial vaginosis solutions, page-29

If you type in "bacterial vaginosis market" on google search

The first thing you see is this


"The current market for the management of BV and associated symptoms is estimated to be in excess of US$750 million globally, with significant areas of unmet need for BV sufferers. Starpharma's modelling suggests the addressable global market for prevention of recurrence of BV is potentially in excess of US$1 billion.".....


DG brought up an interesting comment on another thread recently relating to Starpharma's CEO calling it a day

I personally believe what he suggested could come to pass